Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial

M Salvadori; Mp Scolari; E Bertoni; Franco Citterio; P Rigotti; M Cossu; A Dal Canton; G Tisone; A Albertazzi; F Pisani; G Gubbiotti; G Piredda; G Busnach; V Sparacino; V Goepel; P Messa; P Berloco; D Montanaro; P Veroux; S Federico; M Bartezaghi; G Corbetta; C. Ponticelli

doi:10.1097/TP.0b013e3181bb43ec

Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial

M Salvadori
, Mp Scolari
, E Bertoni
, Franco Citterio
, P Rigotti
, M Cossu
, A Dal Canton
, G Tisone
, A Albertazzi
, F Pisani
, G Gubbiotti
, G Piredda
, G Busnach
, V Sparacino
, V Goepel
, P Messa
, P Berloco
, D Montanaro
, P Veroux
, S Federico

M Bartezaghi, G Corbetta, C. Ponticelli

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo

81 Citazioni (Scopus)

Abstract

In combination with everolimus (EVL), cyclosporine A (CsA) may be used at low exposure, so reducing the risk of renal dysfunction in renal transplant recipients (RTR). We evaluated whether higher exposure of EVL could allow a further reduction of CsA.

Lingua originale	Inglese
pagine (da-a)	1194-1202
Numero di pagine	9
Rivista	Transplantation
Volume	88
DOI	https://doi.org/10.1097/TP.0b013e3181bb43ec
Stato di pubblicazione	Pubblicato - 2009

Keywords

Adolescent
Adult
Aged
Confidence Intervals
Creatinine
Cyclosporine
Dose-Response Relationship, Drug
Drug Therapy, Combination
Humans
Immunosuppressive Agents
Kidney Transplantation
Living Donors
Middle Aged
Patient Compliance
Patient Selection
Sirolimus
Survival Analysis
Treatment Outcome
Triglycerides
Young Adult

Accesso al documento

10.1097/TP.0b013e3181bb43ec

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Salvadori, M., Scolari, M., Bertoni, E., Citterio, F., Rigotti, P., Cossu, M., Dal Canton, A., Tisone, G., Albertazzi, A., Pisani, F., Gubbiotti, G., Piredda, G., Busnach, G., Sparacino, V., Goepel, V., Messa, P., Berloco, P., Montanaro, D., Veroux, P., ... Ponticelli, C. (2009). Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. Transplantation, 88, 1194-1202. https://doi.org/10.1097/TP.0b013e3181bb43ec

@article{31548d8185e9470db730fc36e4bf5ff2,

title = "Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial",

abstract = "In combination with everolimus (EVL), cyclosporine A (CsA) may be used at low exposure, so reducing the risk of renal dysfunction in renal transplant recipients (RTR). We evaluated whether higher exposure of EVL could allow a further reduction of CsA.",

keywords = "Adolescent, Adult, Aged, Confidence Intervals, Creatinine, Cyclosporine, Dose-Response Relationship, Drug, Drug Therapy, Combination, Humans, Immunosuppressive Agents, Kidney Transplantation, Living Donors, Middle Aged, Patient Compliance, Patient Selection, Sirolimus, Survival Analysis, Treatment Outcome, Triglycerides, Young Adult, Adolescent, Adult, Aged, Confidence Intervals, Creatinine, Cyclosporine, Dose-Response Relationship, Drug, Drug Therapy, Combination, Humans, Immunosuppressive Agents, Kidney Transplantation, Living Donors, Middle Aged, Patient Compliance, Patient Selection, Sirolimus, Survival Analysis, Treatment Outcome, Triglycerides, Young Adult",

author = "M Salvadori and Mp Scolari and E Bertoni and Franco Citterio and P Rigotti and M Cossu and \{Dal Canton\}, A and G Tisone and A Albertazzi and F Pisani and G Gubbiotti and G Piredda and G Busnach and V Sparacino and V Goepel and P Messa and P Berloco and D Montanaro and P Veroux and S Federico and M Bartezaghi and G Corbetta and C. Ponticelli",

year = "2009",

doi = "10.1097/TP.0b013e3181bb43ec",

language = "English",

volume = "88",

pages = "1194--1202",

journal = "Transplantation",

issn = "0041-1337",

publisher = "Lippincott Williams and Wilkins",

}

Salvadori, M, Scolari, M, Bertoni, E, Citterio, F, Rigotti, P, Cossu, M, Dal Canton, A, Tisone, G, Albertazzi, A, Pisani, F, Gubbiotti, G, Piredda, G, Busnach, G, Sparacino, V, Goepel, V, Messa, P, Berloco, P, Montanaro, D, Veroux, P, Federico, S, Bartezaghi, M, Corbetta, G & Ponticelli, C 2009, 'Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial', Transplantation, vol. 88, pagg. 1194-1202. https://doi.org/10.1097/TP.0b013e3181bb43ec

TY - JOUR

T1 - Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial

AU - Salvadori, M

AU - Scolari, Mp

AU - Bertoni, E

AU - Citterio, Franco

AU - Rigotti, P

AU - Cossu, M

AU - Dal Canton, A

AU - Tisone, G

AU - Albertazzi, A

AU - Pisani, F

AU - Gubbiotti, G

AU - Piredda, G

AU - Busnach, G

AU - Sparacino, V

AU - Goepel, V

AU - Messa, P

AU - Berloco, P

AU - Montanaro, D

AU - Veroux, P

AU - Federico, S

AU - Bartezaghi, M

AU - Corbetta, G

AU - Ponticelli, C.

PY - 2009

Y1 - 2009

N2 - In combination with everolimus (EVL), cyclosporine A (CsA) may be used at low exposure, so reducing the risk of renal dysfunction in renal transplant recipients (RTR). We evaluated whether higher exposure of EVL could allow a further reduction of CsA.

AB - In combination with everolimus (EVL), cyclosporine A (CsA) may be used at low exposure, so reducing the risk of renal dysfunction in renal transplant recipients (RTR). We evaluated whether higher exposure of EVL could allow a further reduction of CsA.

KW - Adolescent

KW - Adult

KW - Aged

KW - Confidence Intervals

KW - Creatinine

KW - Cyclosporine

KW - Dose-Response Relationship, Drug

KW - Drug Therapy, Combination

KW - Humans

KW - Immunosuppressive Agents

KW - Kidney Transplantation

KW - Living Donors

KW - Middle Aged

KW - Patient Compliance

KW - Patient Selection

KW - Sirolimus

KW - Survival Analysis

KW - Treatment Outcome

KW - Triglycerides

KW - Young Adult

KW - Adolescent

KW - Adult

KW - Aged

KW - Confidence Intervals

KW - Creatinine

KW - Cyclosporine

KW - Dose-Response Relationship, Drug

KW - Drug Therapy, Combination

KW - Humans

KW - Immunosuppressive Agents

KW - Kidney Transplantation

KW - Living Donors

KW - Middle Aged

KW - Patient Compliance

KW - Patient Selection

KW - Sirolimus

KW - Survival Analysis

KW - Treatment Outcome

KW - Triglycerides

KW - Young Adult

UR - http://hdl.handle.net/10807/32850

U2 - 10.1097/TP.0b013e3181bb43ec

DO - 10.1097/TP.0b013e3181bb43ec

M3 - Article

SN - 0041-1337

VL - 88

SP - 1194

EP - 1202

JO - Transplantation

JF - Transplantation

ER -

Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo